Melphalan and Aleve drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melphalan (melphalan) and Aleve (naproxen sodium). Common drug interactions include haematuria among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Melphalan and Aleve. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Aleve?

Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 70,279 Aleve users. Check the latest studies of Aleve.



On Jul, 13, 2026

11 people who take Melphalan and Aleve together, and have interactions are studied.

Melphalan and Aleve drug interactions.

What are the common drug interactions of Melphalan and Aleve, by gender? *:

female:

  1. Haematuria (presence of blood in urine)
  2. Haemophilus infection (bacterial infection by haemophilus influenzae)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Haemorrhage (bleeding)
  5. Hair follicle tumour benign
  6. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  7. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Hypertension (high blood pressure)

male:

  1. Dizziness
  2. Monoclonal immunoglobulin present
  3. Decreased appetite
  4. Diarrhoea
  5. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  6. Fatigue (feeling of tiredness)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Liver disorder (liver diseases)
  9. Mucosal inflammation (infection of mucous membrane)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Melphalan and Aleve, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Glomerular filtration rate decreased
  2. Haematoma (collection of blood outside the blood vessels)
  3. Haematuria (presence of blood in urine)
  4. Haemophilus infection (bacterial infection by haemophilus influenzae)
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Haemorrhage (bleeding)
  7. Hair follicle tumour benign
  8. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  10. Hyperhidrosis (abnormally increased sweating)

50-59:

  1. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  2. Decreased appetite
  3. Diarrhoea
  4. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Mucosal inflammation (infection of mucous membrane)
  7. Nausea (feeling of having an urge to vomit)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Platelet count decreased
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Dizziness
  2. Monoclonal immunoglobulin present
  3. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Pneumonia
  7. Pruritus (severe itching of the skin)
  8. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  9. Thyroid cancer metastatic (thyroid cancer spreads to other part)
  10. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 72.73%
  2. Nausea (feeling of having an urge to vomit): 5 people, 45.45%
  3. Nausea And Vomiting: 4 people, 36.36%
  4. Urinary Tract Infection: 3 people, 27.27%
  5. High Blood Pressure: 3 people, 27.27%
  6. Swelling: 2 people, 18.18%
  7. Stress And Anxiety: 1 person, 9.09%
  8. Sinus Congestion (blockage of sinus): 1 person, 9.09%
  9. Muscle Spasms (muscle contraction): 1 person, 9.09%
  10. Irritable Bowel Syndrome: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and Aleve?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Melphalan and Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aleve:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melphalan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aleve and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on melphalan and naproxen sodium (the active ingredients of Melphalan and Aleve, respectively), and Melphalan and Aleve (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: